“γδT Cell-IL17A-Neutrophil” Axis Drives Immunosuppression and Confers Breast Cancer Resistance to High-Dose Anti-VEGFR2 Therapy

Angiogenesis is an essential physiological process and hallmark of cancer. Currently, antiangiogenic therapy, mostly targeting the vascular endothelial growth factor (VEGF)/VEGFR2 signaling axis, is commonly used in the clinic for solid tumors. However, antiangiogenic therapies for breast cancer pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhigang, Yang, Chenghui, Li, Lili, Zhu, Ying, Su, Ke, Zhai, Lingyun, Wang, Zhen, Huang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554133/
https://www.ncbi.nlm.nih.gov/pubmed/34721375
http://dx.doi.org/10.3389/fimmu.2021.699478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554133/
https://www.ncbi.nlm.nih.gov/pubmed/34721375
http://dx.doi.org/10.3389/fimmu.2021.699478

Ejemplares similares